梯瓦制药Teva Pharmaceutical Industries Limited (TEVA) 2013年CSR报告「NYSE」.pdf

1、1Corporate SocialMeeting Our Patients NeedsResponsibility Report2Teva CSR CEO LetterA Letter From Erez Vigodman,Tevas President&CEOThis approach is not new to Teva:for over 113 years,we have been both passionate and professional about providing better health outcomes for our patients.As one of the t

2、op 12 global pharmaceutical companies and a world leader in Generics,we are committed to increasing access to high-quality,affordable healthcare.With a global product portfolio of more than 1,000 molecules and a direct presence in over 60 countries,Teva offers the largest medicine cabinet in the wor

3、ld,to an exceptionally broad and diverse audience.In 2013,1 out of every 7 prescriptions in the U.S.was filled with a Teva product approximately 1.5 million prescriptions per day.In the U.K.,1 in 6 prescription packs is a Teva medicine.Our broad global reach ensures that we are highly aware of globa

4、l challenges and concerns.Tevas impact extends beyond the products and solutions we supply,to touch the environment,our employees,and the communities in which we work and live.As the worlds largest provider of generic drugs,Teva makes a considerable contribution to the sustainability of healthcare s

5、ystems worldwide by reducing costs and generating significant economic value.For instance,in the US,Teva is responsible for saving$200 billion over the last decade.During the last two decades we have also developed advanced R&D,regulatory,commercial and go to market capabilities in the innovative dr

6、ugs and specialty medicines spaces.Going forward,we aim at targeting a unique space in the industry,at the intersection between innovative and off-patent drugs,in a way that will enable us to meet more and more unmet needs of patients along their journey,with affordable and integrated solutions that